Allergy human

Therapeutic foods have been developed to meet the needs of pets that have nephritic failure, allergies, thyroid problems, geriatric difficulties, and obesity. Most of these therapeutic diets are dispensed by veterinarians, though some are available in pet food outlets and human-food stores stocking pet foods. Treats are usually snacks that may be nutritionally complete or may provide a tasty morsel as a reward. The number of treat products has escalated rapidly. 

In humans, cases of dermatitis have been described after contact with DHBs. Combined exposure to hydroquinone and quinone airborne concentrations causes eye irritation, sensitivity to light, injury of the corneal epithelium, and visual disturbances (126). Cases with an appreciable loss of vision have occurred (127). Long-term exposure causes staining due to irritation or allergy of the conjunctiva and cornea and also opacities. Resorcinol and catechol are also irritants for eyes. 

Allergy A hypersensitivity reaction of the human body due to a particular substance. 

Another potential adverse reaction may be if die patient has an allergy to the animal (pig or cow) from which the insulin is obtained or to the protein or zinc added to insulin. To minimize the possibility of an allergic reaction, some health care providers prescribe human insulin or purified insulin. However, on rare occasions, some individuals become allergic to the human and purified insulins. 

A single case report of skin allergy to methyl parathion has been reported in humans (Lisi et al. 1987). Also see Section 3.2.3.2. 

Immunotoxicity. Only a single case report of skin allergy to methyl parathion has been reported in humans (Lisi et al. 1987). No studies are available in humans exposed to methyl parathion via the inhalation or oral route. Based on limited animal studies, immunotoxicity may be a sensitive end point of methyl parathion-induced toxicity (Shtenberg and Dzhunusova 1968 Street and Sharma 1975). Thus, humans may be at risk for adverse immunological effects following exposure to methyl parathion. The limited information available on the effects of combined exposure to methyl parathion suggest the its toxicity is not route-dependent. Therefore, there is no reason to suspect that the immunotoxic effects observed following oral exposure of animals are route-specific. 

Smith PL. Kagey-Sobotka A. Blecker ER. Traystman R, Kaplan AP. Gralink H. Valentine MD. Permut S. Lichtenstein LM Physiologic manifestations of human anaphylaxis. J Clin Invest 1980 60 1072. Stark BJ. Sullivan TJ Biphasic and protracted anaphylaxis. J Allergy Clin Immunol 1986 78 76-83. Sullivan TJ Cardiac disorders in penicillin-induced anaphylaxis association with intravenous epinephrine therapy. JAMA 1982 248 2161. 

Inhibition of human allergic T-helper type 2 immune responses by induced regulatory T cells requires the combination of interleukin- 10-treated dendritic cells and transforming growth factor-p for their induction. Clin Exp Allergy 2006 36 1546-1555. 

Matsuda K, Piliponsky AM, likura M, Nakae S, Wang EW, Dutta SM, Kawakami T, Tsai M, Galli SJ Monomeric IgE enhances human mast cell chemokine production IL-4 augments and dexam-ethasone suppresses the response. J Allergy Clin Immunol 2005 116 1357-1363. 

H, Devey ME Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non-reactors to clinical dex-tran. Allergy 1982 37 481-489. 

Lie WJ, Homburg CH, Kuijpers TW, Knol EF, Mul FR Roos D, Tool AT Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. Clin Exp Allergy 2003 33 1125-1134. 

Criep LH, Woehler TR The heart in human anaphylaxis. Ann Allergy 1971 29 399... 

Adt M, Marone G Human heart mast cells a definitive case of mast cell heterogeneity. Int Arch Allergy 29 Immunol 1995 106 386. 

Stellato C, de Crescenzo G, Patella V, Mastronardi P. Mazzarella B, Marone G Human basophil/mast cell releasability. XL Heterogeneity of the effects of contrast media on mediator release. J Allergy Clin Immunol 1996 97 838. 

Jogie-Brahim S, Min HK, Fukuoka Y, Xia HZ, Schwartz LB Expression of a-tryptase and 3-tryptase by human basophils. J Allergy Clin Immunol 2004 113 1086-1092. 

Foster B, Schwartz LB, Devouassoux G, Metcalfe DD, Prussin C Characterization of mast-cell try-ptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol 2002 109 287-293. Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, Van del Linden PW Development of a new, more sensitive immunoassay for human tryptase use in systemic anaphylaxis. J Clin Immunol 1994 14 190-204. 

N. Miyazaki E, Kumamoto T. Akiyama K Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Chn Exp Allergy 2009 39 72-80. SO... 

De Week AL, Sanz ML, Gamboa PM, Aberer W, Bienvenue J, Blanca M, Demoly P, Ebo DG, Mayorga L, Monneret G, Sainte Laudy J Diagnostic tests based on human basophils more potential and perspectives than pitfalls. Int Arch Allergy Appl Immunol 2008 146 177-189. 

Clough GF, Boutsiouki P, Church MK Comparison 57 of the effects of levocetirizine and loratadine on histamine-induced wheal, flare, and itch in human skin. Allergy 2001 56 985-988. 58... 

Dermal Effects. Some humans experienced dry throats following acute inhalation exposure to trichloroethylene at 200 ppm (Stewart et al. 1970). Persons working with trichloroethylene for intermediate periods sometimes develop skin rashes and dermatitis (Bauer and Rabens 1974 El Ghawabi et al. 1973). It is reported that some people may be particularly sensitive to trichloroethylene and develop allergies when exposed to high levels in the air or on their skin during oeeupational exposures of intermediate duration (Cziijak et al. 1993 Goh and Ng 1988 Nakayama et al. 1988 Phoon et al. 1984). Exposure to... 

Another set of studies on allergy and inflammation consists of a direct determination of PAF-acether after HPLC purification of human blood extracts. PAF-acether... 

The most effective agent for the treatment (and prophylaxis) of human and animal bite-wound infections is amoxicillin-clavulanate. Alternatives for patients with significant penicillin allergies include either a fluoroquinolone or TMP-SMX in combination with clindamycin. Doxycycline also may be prescribed. The durations of prophylaxis and treatment generally are 3 to 5 and 10 to 14 days, respectively.3... 

Bochner BS, Hudson SA, Xiao HQ, Liu MC. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions. J Allergy Clin Immunol 2003 112(5) 930—934. 

Liu LY, Jarjour NN, Busse WW, Kelly EA. Chemokine receptor expression on human eosinophils from peripheral blood and bronchoalveolar lavage fluid after segmental antigen challenge. J Allergy Clin Immunol 2003 112(3) 556-562. 

Persson T, Monsef N, Andersson P, et al. Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils. Clin Exp Allergy 2003 33(4) 531-537. 

---